Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ginkgo Biomedical Research Institute is a specialized research organization established by Ginkgo Bioworks to advance synthetic biology and biosecurity capabilities. Based in Suzhou, China, the institute focuses on developing innovative solutions for pathogen surveillance, infectious disease monitoring, and public health infrastructure. It utilizes Ginkgo's high-throughput cell programming platform to support global biosecurity initiatives and collaborative R&D projects. The institute serves as a key component of Ginkgo's international strategy, bridging advanced biological engineering with real-world health security applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ginkgo Biomedical Research Institute.